Asciminib and its Impurities
Asciminib, sold under the brand name Scemblix, is a medication used to treat Philadelphia chromosome-positive chronic myeloid leukemia. It is a protein kinase inhibitor. Reference standards of Asciminib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
(R)-N-(4-(Chlorodifluoromethoxy)phenyl)-6-(3-hydroxypyrrolidin-1-yl)-N-nitroso-5-(1H-pyrazol-3-yl)nicotinamide
(R)-N-(4-(Chlorodifluoromethoxy)phenyl)-6-(3-hydroxypyrrolidin-1-yl)-N-nitroso-5-(1H-pyrazol-3-yl)nicotinamide
Catalogue No.:PA 01 3631000
CAS :
NA
Molecular Formula : C20H17ClF2N6O4
Molecular Weight : 478.84
(R)-6-(3-Hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-3-yl)-N-(4-(trifluoromethoxy)phenyl)nicotinamide
(R)-6-(3-Hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-3-yl)-N-(4-(trifluoromethoxy)phenyl)nicotinamide
Catalogue No.:PA 01 3631002
CAS :
1492952-55-2
Molecular Formula : C20H18F3N5O3
Molecular Weight : 433.39
(R)-5-((4-(Chlorodifluoromethoxy)phenyl)carbamoyl)-2-(3-hydroxypyrrolidin-1-yl)nicotinic Acid
(R)-5-((4-(Chlorodifluoromethoxy)phenyl)carbamoyl)-2-(3-hydroxypyrrolidin-1-yl)nicotinic Acid
Catalogue No.:PA 01 3631005
CAS :
NA
Molecular Formula : C18H16ClF2N3O5
Molecular Weight : 427.79
